Nel (NEL) Q4 2017 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2017 earnings summary
17 Oct, 2026Executive summary
Q4 revenue rose to NOK 111.9m from NOK 50.6m YoY; full-year organic growth excluding Proton Onsite was ~40%.
Commercial activity strengthened, with Q4 orders above NOK 110m, backlog at an all-time high of ~NOK 465m, and major opportunities tied to Nikola and H2V.
Year-end cash was NOK 295m, supported by positive Q4 operating cash flow and financing proceeds; production capacity expansion was under evaluation.
Financial highlights
Q4 revenue NOK 111.9m vs NOK 50.6m; FY revenue NOK 298.4m vs NOK 114.5m in 2016, with growth largely reflecting Proton Onsite acquisition.
FY EBITDA was -NOK 81.2m vs -NOK 44.9m; EBIT -NOK 117.2m vs -NOK 55.3m; net loss -NOK 52.4m vs -NOK 55.8m.
Reported Q4 EBITDA was -NOK 27.7m; adjusted Q4 EBITDA was -NOK 11.1m, excluding ramp-up/non-recurring costs and non-cash option costs.
Q4 net profit was NOK 22.7m, versus a loss of NOK 18.5m in Q4 2016; the U.S. tax-rate change added a positive NOK 53.2m net tax effect.
Outlook and guidance
Year-end backlog of ~NOK 465m and cash of NOK 295m intended to support continued development.
Electrolyser capacity expansion from 25MW to 250MW was being evaluated to support potential H2V and Nikola demand; management cited >30% production cost reduction from the ramp-up.
Electrolyser sales leads were at an all-time high across traditional and new markets; production synergies between Norwegian and U.S. operations were being pursued.
Fueling operations planned continued Herning capacity ramp-up, with good 2018 contract coverage and California installation/service preparations for Shell, Sunline and H2Frontier stations.
Solutions activities included pursuing Korea and Europe station contracts, exploring China entry options, and collaborating on a large-scale H2Bus Europe rollout.
Latest events from Nel
- Revenue grew 8% YoY as hydrogen orders expanded, while near-term EBITDA remained under pressure.NEL
Q4 2018 - Q4 revenue rose as hydrogen contracts and renewable projects expanded.NEL
Q4 2016 - Order intake surged as revenue fell, Alkaline weakened and HYDS projects remained at risk.NEL
Q3 2026 - Order intake soared 224% as new technology launched, despite revenue and EBITDA declines.NEL
Q2 2026 - Revenue and orders fell, but EBITDA loss narrowed and new technology launches are underway.NEL
Q1 2026 - Order intake surged and new tech launch is set for 2026 despite heavy impairments and losses.NEL
Q4 2025 - Revenue down 10%, net loss narrowed, and major strategic deals followed Cavendish spin-off.NEL
Q2 2024 - Revenue fell 44% but record PEM order intake and cost cuts support strong cash reserves.NEL
Q1 2025 - Q4 2024 saw improved EBITDA, strong cash, and tech advances amid order and backlog shifts.NEL
Q4 2024